ZAKA VC's book
41 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Mews | Business/Productivity Software | $2.5B | — | — | |
| Sygaldry | — | $548.0M | — | — | |
| ParcelBio | Drug Discovery | $41.2M | — | — | |
| Stackt | — | $35.4M | — | — | |
| Cirrus Therapeutics | — | $26.0M | — | — | |
| HeXembio | — | $25.0M | — | — | |
| Alixia | — | $22.5M | — | — | |
| Prograd | — | $17.1M | — | — | |
| InGel Therapeutics | — | $17.0M | — | — | |
| Kano Therapeutics | Biotechnology | $15.0M | — | — | |
| + 31 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 41 recorded positions
- ·Watchlist + alerts for ZAKA VC's activity
Create free account
No card required